People | March 16, 2024
Indranil Sen, CFO, Biocon resigned
Sen spent a decade with Biocon and held various key roles,
Sen spent a decade with Biocon and held various key roles,
Dalal is an experienced leader at Abbott, having joined in 1995 as a Product Manager
Company reaffirms commitment to reduce the global burden of HPV-related diseases, including certain cancers
Completes acquisition of 75% of share capital from Glenmark Pharmaceuticals
New institute brings together Evonik’s most advanced biotech platform and a global network of evaluation labs
The investment will catalyse various components of the IndiaAI Mission
India has reached to nearly 6,000 bio-startups from 50 in the past 10 years
The validations confirm the completion of the applications and commence the scientific review process
Acquisition of exclusive commercialization rights for European markets
Investigational cell therapy bemdaneprocel continues to be well tolerated with no major safety issues in all 12 participants in low and high dose cohorts through 18 months
Subscribe To Our Newsletter & Stay Updated
